Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
11.77
-0.48 (-3.92%)
Aug 8, 2025, 9:46 AM EDT
Paramount Global Market Cap
Finch Therapeutics Group has a market cap or net worth of $19.98 million as of August 8, 2025. Its market cap has increased by 1,186.93% in one year.
Market Cap
19.98M
Enterprise Value
32.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$11.77
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 19.98M, a decrease of -98.01%. That is a compound annual growth rate of -59.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 19.98M | 10.13% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | 1.01B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 604.98M |
| Glass House Brands | 478.54M |
| Northwest Biotherapeutics | 365.69M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.51M |